Purpose Unlimited’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-562
Closed -$48K – 588
2026
Q2
$48K Buy
+562
New +$40.4K ﹤0.01% 332

Other funds holding CYTK

Purpose Unlimited's CYTK Position: Q3 2026 in Review

Purpose Unlimited sold out of Cytokinetics (CYTK) in Q3 2026, closing a stake of 562 shares — an estimated $48K sold.

Purpose Unlimited first reported a position in CYTK in Q2 2026 and held it in 1 quarter. The position peaked at $48K in Q2 2026. 468 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.

  • Purpose Unlimited reported no remaining Cytokinetics position as of Q3 2026 after selling out during the quarter.
  • Purpose Unlimited sold 562 Cytokinetics shares in Q3 2026, an estimated $48K.
  • Purpose Unlimited first reported a position in Cytokinetics in Q2 2026 and held it in 1 quarter.
  • Purpose Unlimited's Cytokinetics position peaked at $48K in Q2 2026.
  • 468 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.

Based on Purpose Unlimited's 13F filing for Q3 2026, filed 12 Nov 2026.